Kara Kassay
Family Medicine · Portland, ORNPI 1609968759
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 249 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 33 manufacturers, the largest accounting for just 20.8% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2021 at $1,200 and has fallen 89.5% since, to $126 in 2025. Among family medicine clinicians in OR with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 249 payments — averaging $20.18 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$1K
- Amgen$719
- Johnson & Johnson$496
- Boehringer Ingelheim$350
- Merck$298
- AstraZeneca$193
- plus $2K from 27 others
What the payments were for
- Food & beverage$5,024100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 58 | $1,044 |
| Amgen | 34 | $719 |
| Johnson & Johnson | 21 | $496 |
| Boehringer Ingelheim | 14 | $350 |
| Merck | 17 | $298 |
| AstraZeneca | 12 | $193 |
| Pfizer | 10 | $191 |
| Novo Nordisk | 10 | $179 |
| Teva Pharmaceuticals USA, Inc. | 7 | $171 |
| GSK | 8 | $158 |
| Amarin Pharma, Inc. | 8 | $156 |
| Lilly USA, LLC | 7 | $147 |
| Exact Sciences | 5 | $121 |
| Eisai Inc. | 5 | $101 |
| Coala Life Inc | 3 | $80 |
| Therapeuticsmd, Inc. | 4 | $79 |
| Bausch Health US, LLC | 3 | $73 |
| E.r. Squibb & Sons, L.L.C. | 3 | $67 |
| Shire North American Group Inc | 2 | $46 |
| Biohaven Pharmaceuticals, Inc. | 3 | $42 |
| Medtronic(2 entities) | 2 | $40 |
| Circassia Inc. | 2 | $30 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $24 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $24 |
| Exeltis, USA Inc. | 1 | $24 |
| Vertex | 1 | $24 |
| Gilead | 1 | $24 |
| Corcept Therapeutics | 1 | $23 |
| Si-bone, Inc. | 1 | $22 |
| Daiichi Sankyo Inc. | 1 | $22 |
| IBSA Pharma Inc. | 1 | $21 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $19 |
| Currax Pharmaceuticals LLC | 1 | $16 |
How this compares
$5,024 in reported general payments places this provider in the 95th percentile of 1,221 family medicine providers in Oregon.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Rosuvastatin Calcium | 53 | $642 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 11 | $302 |
| Sertraline Hcl | 13 | $281 |
| Gabapentin | 11 | $197 |
| Levothyroxine Sodium | 12 | $173 |
| Lisinopril | 32 | $166 |
| Hydrochlorothiazide | 14 | $81 |
| Amlodipine Besylate | 14 | $43 |
Paid to pharmacies, not to this prescriber.
Other family medicine in Portland
- Robert GobboPortland$53K
- Maureen MaysPortland$24K
- Terena GimmillaroPortland$13K
- Carson BauderPortland$8K
- Alexandra Verdieck DevlaeminckPortland$5K
- Whitney RoperPortland$4K
- Eden MillerBend$1.7M
- Anil RajaniHood River$325K
- Stephen NelsonMedford$101K
- Karen KahnAshland$86K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.